*By Carlo Versano*
The world's largest beverage maker is reportedly eyeing the red-hot cannabis market, according to a [report] (https://www.bnnbloomberg.ca/coca-cola-in-talks-with-aurora-to-develop-cannabis-drinks-sources-1.1138528).
Coca-Cola is in "serious talks" with Aurora Cannabis to develop cannabidiol-infused beverages, according to BNN Bloomberg.
A deal on that scale would likely dwarf agreements made by Corona-maker Constellation Brands and Molson Coors, both of which have partnered with Canadian cannabis companies to add CBD, the non-psychoactive ingredient in cannabis that can be used to treat pain or anxiety, to drinks like coffee, soda, and beer, and would represent a "mainstreaming" of pot products in the eyes of Wall Street.
For Coke, getting into the weed market would be both capturing a trend and a diversification play. Soda sales have been down as younger consumers seek out healthier drinks like sparkling water.
Shares of Aurora were up over 6 percent on the news Monday morning, as were other pot stocks like Tilray.
Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.
After years of being told that red wine was good for heart health, more Americans appear to be heeding warnings that even moderate alcohol consumption can be unhealthy.
Amazon is now rolling out a service where its Prime members can order their blueberries and milk at the same time as their batteries and other basic items.
Dr. Richard Besser, President & CEO of the Robert Wood Johnson Foundation and former CDC acting director, unpacks the impact of RFK's mRNA funding cuts.
Jessica Inskip, Director of Investor Research at StockBrokers.com and host of MarketMakeHer, unpacks earnings, market outlook, and what history says is next.
Laura Desmond, CEO of Smartly, explores how Big Tech giants are competing for ad dollars in a shifting digital landscape and how Smartly is here to help.
